MX2012001890A - Sales de lenalidomida. - Google Patents
Sales de lenalidomida.Info
- Publication number
- MX2012001890A MX2012001890A MX2012001890A MX2012001890A MX2012001890A MX 2012001890 A MX2012001890 A MX 2012001890A MX 2012001890 A MX2012001890 A MX 2012001890A MX 2012001890 A MX2012001890 A MX 2012001890A MX 2012001890 A MX2012001890 A MX 2012001890A
- Authority
- MX
- Mexico
- Prior art keywords
- acid
- lenalidomide
- sulfonic acid
- salts
- lenalidomide salts
- Prior art date
Links
- GOTYRUGSSMKFNF-UHFFFAOYSA-N lenalidomide Chemical class C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O GOTYRUGSSMKFNF-UHFFFAOYSA-N 0.000 title abstract 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229960004942 lenalidomide Drugs 0.000 abstract 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
- 229940092714 benzenesulfonic acid Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 abstract 1
- 229940098779 methanesulfonic acid Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a sales de adición de ácido de lenalidomida, en donde el ácido tiene un pKa menor a 1, preferiblemente seleccionado de ácido clorhídrico, ácido bromhídrico, ácido metansulfónico, ácido etansulfónico, ácido bencensulfónico, y ácido p-toluensulfónico, a procesos para su fabricación, y uso en medicina, y a la purificación de la base de lenalidomida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2009/006857 WO2011018101A1 (en) | 2009-08-12 | 2009-08-12 | Lenalidomide salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012001890A true MX2012001890A (es) | 2012-03-26 |
Family
ID=41328475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012001890A MX2012001890A (es) | 2009-08-12 | 2009-08-12 | Sales de lenalidomida. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8686153B2 (es) |
| EP (1) | EP2464638A1 (es) |
| AU (1) | AU2009350978A1 (es) |
| BR (1) | BR112012003138A2 (es) |
| EA (1) | EA201270261A1 (es) |
| MX (1) | MX2012001890A (es) |
| WO (1) | WO2011018101A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| KR20100124710A (ko) * | 2008-03-11 | 2010-11-29 | 닥터 레디스 레보러터리즈 리미티드 | 레날리도미드의 제조 |
| US20110060010A1 (en) * | 2008-03-13 | 2011-03-10 | Tianjin Hemay Bio-Tech Co., Ltd | Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| EP2355802A1 (de) * | 2008-11-14 | 2011-08-17 | Ratiopharm GmbH | Intermediate und orale darreichungsformen enthaltend lenalidomid |
| US9808450B2 (en) | 2013-03-26 | 2017-11-07 | Celgene Corporation | Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof |
| EP3135275B1 (en) | 2015-08-27 | 2020-05-13 | Grindeks, A Joint Stock Company | Pharmaceutical composition capable of the incorporation of lenalidomide in various crystalline modifications |
| WO2019092752A2 (en) * | 2017-11-13 | 2019-05-16 | Avra Laboratories Pvt. Ltd. | Novel salt of lenalidomide and polymorphic forms thereof |
| EP3505158A1 (en) | 2017-12-27 | 2019-07-03 | KRKA, d.d., Novo mesto | Pharmaceutical composition of lenalidomide pharmaceutically acceptable acid addition salt |
| CN117794909A (zh) * | 2021-08-04 | 2024-03-29 | 株式会社艾比斯生物 | 改进物质特性的免疫调节酰胺衍生物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| US6281230B1 (en) * | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| MX2007002521A (es) * | 2004-09-03 | 2007-05-09 | Celgene Corp | Procesos para la preparacion de 2-(2,6-dioxopiperidin-3-il)-1- oxoisoindolinas sustituidas. |
| KR20100124710A (ko) | 2008-03-11 | 2010-11-29 | 닥터 레디스 레보러터리즈 리미티드 | 레날리도미드의 제조 |
| CN101531653B (zh) * | 2008-03-13 | 2014-07-09 | 峡江和美药业有限公司 | 3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基)哌啶-2,6-二酮及其衍生物的盐或盐的多晶型物及其制备和应用 |
-
2009
- 2009-08-12 EA EA201270261A patent/EA201270261A1/ru unknown
- 2009-08-12 AU AU2009350978A patent/AU2009350978A1/en not_active Abandoned
- 2009-08-12 MX MX2012001890A patent/MX2012001890A/es not_active Application Discontinuation
- 2009-08-12 EP EP09740847A patent/EP2464638A1/en not_active Withdrawn
- 2009-08-12 WO PCT/EP2009/006857 patent/WO2011018101A1/en not_active Ceased
- 2009-08-12 BR BR112012003138A patent/BR112012003138A2/pt not_active IP Right Cessation
- 2009-08-12 US US13/390,204 patent/US8686153B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20120190711A1 (en) | 2012-07-26 |
| EA201270261A1 (ru) | 2012-07-30 |
| AU2009350978A1 (en) | 2012-04-05 |
| US8686153B2 (en) | 2014-04-01 |
| BR112012003138A2 (pt) | 2016-03-01 |
| WO2011018101A1 (en) | 2011-02-17 |
| EP2464638A1 (en) | 2012-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012001890A (es) | Sales de lenalidomida. | |
| CL2014000659A1 (es) | Compuestos derivados de 2-(1,2,3-triazol-2-il)benzamida y 3-(1,2,3-triazol-2-il)picolinamida, antagonistas del receptor de orexina; composicion farmaceutica; y su uso para la prevencion o el tratamiento de una enfermedad seleccionada del grupo que consiste en trastornos de ansiedad, adiccion, animicos y del apetito. | |
| MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
| ATE544804T1 (de) | Teilaromatisches copolyamid und herstellungsverfahren dafür | |
| EP2382040A4 (en) | ADIABATIC REACTOR FOR THE PRODUCTION OF OLEFINES | |
| MX2012006553A (es) | Anticuerpos contra csf-1r humano y usos de los mismos. | |
| BRPI1010128A2 (pt) | "processo para a fabricação do 2,3,3,3 - tetrafluropropeno" | |
| SG162671A1 (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| GEP20125407B (en) | New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3- benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| GT201100300A (es) | Piperidinas sustituidas | |
| UA97401C2 (ru) | Экструдат с улучшенной маскировкой вкуса | |
| MY150014A (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| ZA201004467B (en) | Triazolopyridazines as pari inhibitors,production thereof,and use as medicaments | |
| DE502007002185D1 (de) | Verwendung von zusammensetzungen enthaltend kappa-opioidrezeptor-antagonisten zur behandlung von dissoziativen störungen | |
| MY169295A (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| EP2438988A4 (en) | CATALYST FOR THE PRODUCTION OF MONOCYCLIC AROMATIC HYDROCARBONS AND METHOD FOR THE PRODUCTION OF MONOCYCLIC AROMATIC HYDROCARBONS | |
| BRPI0910429A2 (pt) | mistura para a produção de comprimidos de desintegração rápida | |
| CR20110627A (es) | Piperidinas sustituidas | |
| EA200970816A1 (ru) | Новая лекарственная форма | |
| PH12017500270A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain | |
| MY145611A (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
| UA96476C2 (ru) | Фармацевтические композиции, которые содержат ирбесартан | |
| IL207190A (en) | A process for ultra-purification of alginates | |
| UA96574C2 (ru) | Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции | |
| SE0701694L (sv) | Nya bronkdilaterande a,b-omättade amider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |